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Abstract
Breast cancer screening by mammography has been shown to reduce breast cancer morbidity and 
mortality. The use of mammography screening though varies by race, ethnicity, and, 
sociodemographic characteristics. Medicaid is an important source of insurance in the US for low-
income beneficiaries, who are disproportionately members of racial or ethnic minorities, and who 
are less likely to be screened than women with higher socioeconomic statuses. We used 2006–
2008 data from Medicaid claims and enrollment files to assess racial or ethnic and geographic 
disparities in the use of breast cancer screening among Medicaid-insured women at the state level. 
There were disparities in the use of mammography among racial or ethnic groups relative to white 
women, and the use of mammography varied across the 44 states studied. African American and 
American Indian women were significantly less likely than white women to use mammography in 
30% and 39% of the 44 states analyzed, respectively, whereas Hispanic and Asian American 
women were the minority groups most likely to receive screening compared with white women. 
There are racial or ethnic disparities in breast cancer screening at the state level, which indicates 
that analyses conducted by only using national data not stratified by insurance coverage are in-
sufficient to identify vulnerable populations for interventions to increase the use of mammography, 
as recommended.
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1. Introduction
Breast cancer screening by mammography has been shown to reduce disease and death by 
detecting breast cancer early, when treatment is most effective (Elmore et al., 2005; Nelson 
et al., 2009). In 2002, the US Preventive Services Task Force (USPSTF) recommended 
screening mammography, with or without a clinical breast exam, every 1–2 years for women 
aged 40 years or older (USPSTF, 2002). In 2009, the USPSTF changed its breast cancer 
screening recommendations to biennial mammography for women aged 50–74 years 
(USPSTF, 2009) and indicated that the decision to start mammography screening before age 
50 should be an individual one; similar recommendations were made in 2016 (USPSTF, 
2016). The Affordable Care Act of 2010 (ACA) (Patient Protection and Affordable Care Act 
of 2010, n.d), on the basis of the 2002 USPSTF recommendations, requires most insurance 
plans to provide breast cancer screening with no cost sharing, and the Healthy People 2020 
objective is to increase the proportion of women who receive a breast cancer screening to 
81.1%, based on the most recent guidelines (HP, 2016). Meeting this target is a challenge for 
populations with low incomes, no health insurance, or no usual source of care (Brown et al., 
2014).
Lower screening use has been associated with later stage diagnosis and higher morbidity and 
mortality rates among underserved populations, including Medicaid enrollees (Bradley et al., 
2008; Kuo et al., 2010; Horner et al., 2009). Access to screening and treatment services are 
crucial because breast cancer has the greatest likelihood of being successfully treated when 
detected early (Martin and Wingfield, 2012; Malmgren et al., 2012). Use of mammography 
varies by several demographic characteristics, insurance status (Sabatino et al., 2015), some 
racial or ethnic groups (Shoemaker and White (2016a, 2016b); Cobb et al., 2014), and 
across states (Miller et al., 2012; Mobley et al., 2008, 2009). For example, state-level 
mammography use ranged from 65.7% (Idaho) to 83.8% (Delaware) during 2000–2006 
(Miller et al., 2009). By using BRFSS data from 2000 at the county level, Schneider et al. 
(2010) found the highest mammography use in the New England, North and South Atlantic, 
and East North Central census divisions, and the lowest mammography use in the Mountain 
states and Texas.
Although existing studies have demonstrated substantial geographic variation in screening 
use (Miller et al., 2012), little is known about the geographic variation in screening patterns 
among Medicaid women particularly at the state level. Understanding the difference in 
screening rates among the states can help develop tailored breast cancer screening promotion 
interventions that would increase screening rates for specific populations with low screening 
compliance; national estimates can mask local variation. Medicaid is an important source of 
insurance for low-income beneficiaries and racial or ethnic minorities (KFF Brief, 2015), 
who are less likely to be screened than those with higher socioeconomic status (Sabatino et 
al., 2015). All the states and the District of Columbia’s Medicaid programs cover screening 
mammograms, and Medicaid enrollment has also increased among states that have accepted 
Medicaid expansion available through the ACA (Sommers et al., 2014).
This study assesses racial or ethnic and geographic disparities in the use of breast cancer 
screening among Medicaid beneficiaries so that target areas may be identified to improve the 
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use of screening services. In addition, this study provides benchmarks to help measure the 
potential effect of increased enrollment among the Medicaid population.
2. Methods
We used 3 years of Medicaid claims and enrollment files from 2006 to 2008 for this 
analysis. Our inclusion and exclusion criteria were as follows: (1) included Medicaid 
enrollees aged 40–64 years; (2) excluded individuals previously diagnosed with cancer, 
pregnant, residing in long-term care facilities, or who were dual Medicare/Medicaid 
enrollees; and (3) excluded enrollees with restricted benefits because of alien status, 
pregnancy-related services, and Breast and Cervical Cancer Prevention and Treatment Act 
benefits.
We used both fee-for-service (FFS) claims and encounter (managed care) data provided by 
the Centers for Medicare and Medicaid Services. We included encounter data because 
research shows that encounter data quality has improved (Byrd and Dodd, 2012), and 
omitting these data would reduce the sample of Medicaid-insured women considerably 
among states in which managed care penetration is pervasive. We compared mammography 
use by using FFS and encounter claims to assess the quality of the encounter data and to 
verify completeness in each state. When mammography use was lower by using encounter 
data versus FFS data (>3 percentage points), we only included FFS claims for those specific 
states to ensure that potentially incomplete encounter data were not included. We excluded 
six states and District of Colombia (DC): three states (Alabama, Delaware, and Nevada) did 
not have sufficient sample to run the model by using only FFS claims to assess quality of the 
available data; three other states (Alaska, Hawaii, and Maine) did not have complete data for 
all necessary variables; and DC did not have sufficient sample size to perform a meaningful 
analysis. The study population included 3,821,084 women from 44 states.
For our outcome variable, based on the 2002 USPSTF recommendations, we created a 
personal indicator of whether mammography had been received at least once by the 
individual during a 3-year interval. Pooling 3 years of data provides more robust usage 
profiles than 1 or 2 years of data, (i.e., a woman is more likely to be screened during a 3-
year interval than during 1 or 2-year intervals). In addition, because women who use 
Medicaid often experience gaps in coverage, using a longer timeframe is likely to provide 
more consistent estimates. Thus we used 3-years interval to ensure that we have an adequate 
timeframe to capture women with recommendations of undergoing mammograms every 2 
years. If there were some delays then we would still capture their mammograms with a 3-
year window instead of a 2-year window. Our goal was to capture as much mammography 
use behavior by the population who uses Medicaid as we could so that disparities in use can 
be examined. We linked the annual files by using de-identified Medicaid personal identifiers 
and created an indicator of whether a woman used mammography during the 3-year interval. 
This indicator was the outcome variable in a multilevel regression model using individual 
and county-level variables. We combined the person-specific Medicaid data with the area-
level data on the basis of county of residence.
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2.1. Empirical model specification
By using data from the eligible sample of women who use Medicaid, we estimated separate 
regression models for each state, including person and county covariates. This approach 
allowed us to assess screening disparities relative to white women at the state level. We 
specified race on the basis of the coding provided in the Medicaid enrollment data; race was 
categorized as white, non-Hispanic (white); black, non-Hispanic (black); American Indian/
Alaska Native, non-Hispanic (AI/AN); Asian/Pacific Islander, non-Hispanic (A/PI); and 
Hispanic. Person-level characteristics included in the model were age, race or ethnicity, type 
of insurance (FFS or managed care), and disability status. Number of months enrolled in 
Medicaid was included as a control variable because people with shorter tenure would have 
lower observed odds of use.
We included county-level factors from a public database (RTI, 2016; Mobley and Kuo, 2016; 
Mobley et al., 2017) on the basis of the county of person’s residence because social forces, 
such as racial segregation and poverty, may be important determinants of demand. To make 
our findings comparable with recent literature, we used the county-level isolation index of 
residential segregation to reflect societal factors (Mobley et al., 2012). Residential 
segregation indices (by several race or ethnicity groups relative to white) measured the 
degree to which minorities live together, rather than among white populations. We included 
persistent poverty as a measure of deprivation, which records the county’s status during the 
past 25 years. Other contextual variables that may affect demand conditions were migration 
and percentage uninsured. The migration variable reflected the proportion of residents who 
moved into the county from another state during the past 5 years. The migration variable 
was included to reflect communities that were growing more rapidly, and may suggest 
growing demand for health care services. The percentage of uninsured persons reflects the 
populations not eligible for Medicaid, as well as those who voluntarily avoid or cannot 
afford health insurance coverage. The percentage uninsured reflects communities with lower 
health care services demand.
To reflect supply-side factors, we included the proportion of the county population who are 
living in rural areas and the average distance to closest provider, calculated on the basis of 
ZIP code centroids within the county and Medicare patient flows. These average distances 
from 100% FFS Medicare populations to closest provider of mammography services within 
their county of residence were included in an extensive public-use geospatial database (RTI, 
2016). It is the most comprehensive measure of distance-based accessibility available to 
describe the spatial layout of providers across the entire United States. Rural aspect is 
measured by the proportion of the county population living in rural areas, as defined by the 
US Census in 2000 from decennial census data.
2.2. Estimation and translation of findings
Recognizing that individual states’ political, regulatory and health service environments are 
unique, we examine states separately. The two-level model nests Medicaid-eligible women 
in their counties of residence, and includes person-level characteristics with county-level 
contextual variables. The statistical model is a Generalized Estimating Equations (GEE) 
multilevel specification estimated by using SAS GENMOD. The GEE model adjusts the 
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standard errors of the county-level contextual variables to reduce the bias to standard errors 
that results from repeated (redundant) county measures for all women living in each county 
(Oakes, 2004). The GEE approach is appropriate when the outcome variable is binary and 
when researchers are concerned with estimating robust population-level effects (Hardin and 
Hilbe, 2003; Gelman and Hill, 2007).
Separate regressions on the population-level estimates of disparities in mammography use 
among minorities and white populations in each of the 44 states included in this study 
resulted in a large volume of empirical findings; 44 tables each with 18 covariates used as 
regressors. The model includes 17 covariates that reflect both supply and demand factors at 
the county level, as well as individual level ‘enabling-predisposing-need’ factors from the 
classic Aday and Anderson (1974) framework; this formed the basis of our conceptual 
model (see Appendix A for more details). All variables were maintained in the model 
regardless of their statistical significance. To translate the findings and present the racial or 
ethnic disparities relative to white, we created and displayed four maps of the United States 
together in a single graphic. Each map displays the disparity of a single racial or ethnic 
group relative to white, derived from the separate regression estimates for each state. When 
the disparities estimate is statistically significant and negative (odds ratio < 1), the state is 
colored red. When the estimate is statistically significant and positive (odds ratio > 1), the 
state is colored blue. When the estimates for the minority are not significantly different from 
white, the state is colored grey. This mapping of regression coefficients for spatial 
translation of the research findings allows the large volume of estimates to be condensed and 
visually compared across all of the states.
In addition, we also present summary statistics by state for the higher and lower odds of 
receiving mammograms, compared to white women, to identify the magnitude of the 
potential differences. We provide the median (instead of mean because of outliers), range, 
and total number of states that have statistically significant racial or ethnic differences in 
mammography screening use.
3. Results
Table 1 provides the sample counts and proportions of women who received at least one 
mammogram during 2006–2008 among 44 states. The cohort of Medicaid beneficiaries and 
number of counties vary widely across the states. The highest and lowest values of the 
variables in the table are highlighted in bold. The state with the largest number of female 
Medicaid beneficiaries was California, whereas Wyoming had the smallest sample. 
Mammography use was the highest in Rhode Island (45%), Vermont (42%), Connecticut 
(41%), and West Virginia (40%), whereas it was the lowest in Maryland (17%), Arkansas 
(19%), Florida (19%), and Ohio (19%). The proportion of racial or ethnic groups also varied 
by state. Among people on Medicaid, California had the highest proportion of Hispanic 
women; Mississippi had the highest proportion of blacks; South Dakota had the highest 
proportion of AI/AN; and New York had the highest proportion of A/PI women, followed by 
California.
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Fig. 1 shows racial and ethnic disparities in mammography use among state Medicaid 
programs. Overall, AI/AN women were significantly less likely to use mammography than 
white women in 17 states (colored red on map), and more likely to use mammography than 
white women in 2 states (Michigan and New Mexico; colored blue on map). In the 
remaining 25 states, AI/AN women were not significantly different from white women in 
their likelihood of using mammography (colored grey on map). Black women were 
significantly less likely than white women to use mammography in 13 states, whereas black 
women were significantly more likely to use mammography than white women in 6 states 
(CT, GA, MD, OH, PA, VA).
A/PI women were significantly less likely than white women to use mammography in only 4 
states (IN, MO, MN, WI), whereas A/PI women were significantly more likely to use 
mammography than white women in 18 states. Hispanic women were significantly less 
likely than white women to use mammography in only 1 state, Oregon, and in 24 states 
Hispanic women were significantly more likely to use mammography than white women.
Table 2 presents a summary of statistics about the higher and lower median odds of 
receiving mammography screening for each racial or ethnic group as compared with white 
women. Although both AI/AN and black women have the largest number of states with 
lower odds of screening than among white women, AI/AN women have lower odds ratios 
than black women (OR of 0.59 compared to 0.85). Although A/PI women only experience 
screening disparities in 4 states, the odds of not receiving screening in these states are 
similar to those reported by AI/AN women (OR = 0.58). Hispanic women were most likely 
to receive screening (OR = 1.43) compared with white women, followed by A/PI women 
(OR = 1.32).
4. Discussion
In this paper, we focused on racial or ethnic disparities for receiving mammography 
screening (compared to white women) among Medicaid-insured women at the state level. 
Black and AI/AN women had lower mammography usage relative to white women in 30 and 
39% of the 44 states analyzed, respectively. However, both groups showed higher 
mammography usage in a few states. Hispanic and Asian American women were less likely 
to experience disparities and had a lower probability of mammography screening compared 
to white women in only a few states. A recent study of Asian American women did reveal 
that there are differences in the patterns of mammography screening among Asian women 
by length of residency in the United States, insurance status, and usual source of care 
(Shoemaker and White (2016a, 2016b)).
National mammography screening usage reported in the 2013 National Health Interview 
Survey showed no differences in the proportion who had a mammogram within the past 2 
years between black and white women overall, but there were large differences in 
mammography usage by health insurance coverage and usual source of care (Sabatino et al., 
2015).
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By focusing on women served by Medicaid at the state level, our results reveal that black 
women experience disparities in mammography screening in some geographic locations 
compared with white women. These differences are masked when pooled national level 
analyses are performed. Our state-level analysis also indicated lower screening use for 
AI/AN women, except in two states where the individuals had a significantly higher rate of 
mammography screening than white women. AI/AN women might have received screening 
mammograms through the Indian Health Service; hence, this information would not have 
been captured in the Medicaid claims, which may result in an underestimate of screening 
performed for AI/AN women. Cobb and colleagues also reported some regional variation in 
cancer screening among AI/AN women, who were less likely to be up-to-date with 
screening recommendation than white women (Cobb et al., 2014).
State Medicaid policies may partially explain differences between states in disparities 
among Medicaid insured women by race or ethnicity. However, the state Medicaid policies 
generally affect all women enrollees in the state and, therefore, may have negligible 
differential effects (Coburn et al., 1999; Baker and Royalty, 2000; Guy, 2010). A recent 
study using the same Medicaid data as analyzed in this study (Mobley et al., 2017) found 
that black residential segregation resulted in lower levels of mammography screening, that 
is, living among more segregated black communities had lower odds ratio compared to areas 
with low segregation. In addition, this study also reported that women living in states with 
expanded scope of practice, where nurse practitioners can provide primary care independent 
of physician oversight, had higher screening rates compared with women residing in more 
restrictive states. State level differences in these factors could result in lower levels of 
mammography screening, especially among minorities. Another study that analyzed 
Behavior Risk Factor Surveillance System data found that those with higher income and 
education levels were more compliant with mammography recommendations (Narayan et 
al., 2017). Therefore, state level differences in education and income among Medicaid 
minority groups could also impact disparities in breast cancer screening.
The strength of this analysis is that we are able to assess racial or ethnic differences for each 
state rather than compare racial disparities across the nation. Other studies that use a national 
perspective (e.g., Halpern et al., 2014; Jemal et al., 2012) can provide generalized estimates 
of disparity at the national level, but these can be confounded by racial or ethnic groups that 
tend to cluster geographically (Intrator et al., 2016). Some geographic areas with high 
prevalence of racial or ethnic groups are poorer areas where everyone uses less health care. 
But because racial or ethnic groups often reside in segregated communities with lower 
socioeconomic status, national estimates of disparities in the use of mammography will pick 
up differences among individuals on the basis of the differences in populations located 
across regions (Mobley et al., 2008). Community barriers and facilitators can explain some 
of the differences in disparities across the states. Local customs and cultures, as well as 
topography and physical barriers to access health care services, may affect some residential 
enclaves more than others.
The limitations of this analysis include the quality of the data available. Small samples for 
racial groups, especially AI/AN, could affect the amount of statistical power available to 
distinguish between a true and false null hypothesis (hypothesis: no racial effect). However, 
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even when groups are small, given a strong enough signal, there will be sufficient power to 
detect an effect (significantly different from zero). In addition, we analyzed both fee-for-
serve claims and encounter data, and because both of these Medicaid data sources are 
primarily collected for administrative purposes, the information may not be complete or 
accurate at the level of detail required for health services research. Women could have also 
received screening through other programs, such as National Breast and Cervical Cancer 
Early Detection Program (NBCCEDP) or through the Indian Health Service (IHS), and these 
screens would not be captured in the data analyzed. On the basis of the limited coverage of 
NBCCEDP and IHS, this exclusion would result in very minimal bias (Howard et al., 2015). 
Given the discontinuous nature of health care coverage and the multiple programs that may 
serve low-income women, additional studies could be performed to confirm the findings 
from this analysis. These studies could involve patient surveys to confirm and supplement 
findings from Medicaid claims data.
The findings from this study reveal that Medicaid claims information is a useful resource for 
analysis of racial or ethnic differences in breast cancer screening at the state level or below. 
Additional research should be undertaken to explain the reasons for the observed state-level 
variation in this study and to also perform analyses using more recent data to assess relevant 
policy changes. Research could be performed to understand the potential impact of changes 
in USPSTF recommendations and mammography screening among women 40 to 50 years of 
age and enrolled in Medicaid. In addition, future studies could also examine how these 
patterns may have changed with implementation of the ACA in 2010 and provisions phased 
in during the subsequent years. The ACA offers coverage for mammograms without copays 
in many health plans, and the effect of this policy change could be studied across racial or 
ethnic and geographic areas. Additional assessments could also be performed to assess the 
effects of these screening differences on the final outcomes of individuals using state-level 
cancer registry data available from the CDC’s National Program of Cancer Registries or the 
National Cancer Institute’s Surveillance, Epidemiology, and End Results program. The key 
finding from the present study is that state level mammography use among Medicaid 
beneficiaries shows racial or ethnic disparities that may be masked in national-level 
analyses.
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Appendix A. Statistical analysis and model variables
For each state, we estimated an independent model with person and county level covariates 
(see Appendix Table 1 below). Because the county data values were redundant across 
individuals residing in the same county, we used SAS GENMOD to adjust their standard 
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errors for reliable inference. Residential isolation indices and a population migration 
measure were included as measures of social integration or support in the county of 
residence. By holding constant these area level factors that could influence where women 
decided to live, we are better able to isolate robust disparity estimates across the races and 
ethnicities that are comparable across the states.
Appendix Table 1
Variables used in analysis and sources.
Variables used in estimation Source
Person level
 Age RTI-CDC Medicaid data
 Number months enrolled RTI-CDC Medicaid data
 Has disability RTI-CDC Medicaid data
 Had HMO coverage RTI-CDC Medicaid data
 AI/AN, non-Hispanic RTI-CDC Medicaid data
 Asian/PI, non-Hispanic RTI-CDC Medicaid data
 Black, non-Hispanic RTI-CDC Medicaid data
 Hispanic RTI-CDC Medicaid data
 All others RTI-CDC Medicaid data
County level
 Isolation index, Asians 2005–2009 US Census
 Isolation index, blacks 2005–2009 US Census
 Isolation index, Hispanics 2005–2009 US Census
 Proportion of area population who moved from another state during 
2005–09
US Census
 Average distance in miles to closest mammogram facility in 2006 RTI calculations based on 100% FFS 
Medicare files
 Proportion population uninsured in 2005 US Census
 Lived in a county w/persistent poverty 1979–2005 US Census
 Proportion population rural in 2000 US Census
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Fig. 1. 
Disparities in Medicaid population mammography use 2006–2008: racial or ethnic groups 
relative to whites. Fig. 1 MAPS LEGEND: We used Medicaid claims and enrollment files to 
assess racial or ethnic disparities in the use of breast cancer screening (mammography use 
over a 3-year period) among Medicaid-insured women at the state level. All disparities are 
statistically significant differences relative to white groups. States colored blue are those 
with a mammography screening use among racial or ethnic groups that is significantly 
higher than white groups. States colored red are those with mammography screening use 
among racial or ethnic groups that is significantly lower than white groups. States colored 
grey have the same mammography screening use among racial or ethnic groups and white 
groups. States colored pale yellow are those that did not meet the inclusion criteria.
Source: 2006–2008 Medicaid claims and encounter data merged with county level data from 
the 2000 US Census.
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Table 2
Summary of higher or lower odds of mammography use compared with white groups. Source: 2006–2008 
Medicaid claims and encounter data.
Lower odds of mammography for the racial 
or ethnic groups compared with white 
groupsa
Higher odds of mammography for the racial 
or ethnic groups compared with white 
groupsa
Median [range] (no. of states) Median [range] (no. of states)
Non-Hispanic black 0.85 [0.60–0.93] (n = 13) 1.10 [1.08–1.23] (n = 6)
Non-Hispanic American Indian/Alaska 
Native
0.59 [0.36–0.88] (n = 17) 1.21 [1.13–1.28] (n = 2)
Non-Hispanic Asian/Pacific Islander 0.58 [0.36–0.66] (n = 4) 1.32 [1.17–2.11] (n = 18)
Hispanic 0.73 [n/a] (n = 1) 1.43 [1.08–2.04] (n = 24)
aOnly statistically significant differences are included in these estimates.
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